ask="3.00"
ask_size="1900"
average_daily_volume="58437"
bid="1.26"
bid_size="100"
book_value="0.95"
change="+0.01"
change_from_200_day_moving_average="-0.10"
change_from_50_day_moving_average="0.02"
change_from_52_week_high="-0.70"
change_From_52_week_low="0.16"
change_in_percent="+0.78%"
close="1.30"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.75"
ebitda="-28.78M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-1.07"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.37"
high_52_weeks="2.00"
last_trade_date="1/20/2017"
last_trade_price="1.30"
last_trade_size="257"
last_trade_time="4:00pm"
low="1.28"
low_52_weeks="1.14"
market_capitalization="50.23M"
moving_average_200_day="1.40"
moving_average_50_day="1.28"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="1.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.24%"
percent_change_from_50_day_moving_average="+1.92%"
percent_change_from_52_week_high="-35.00%"
percent_change_from_52_week_low="+14.04%"
previous_close="1.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.36"
price_per_sales="6.47"
revenue="7.70M"
shares_outstanding="38640000"
short_ratio="1.90"
stock_exchange="NMS"
symbol="AVIR"
volume="41690"
weeks_range_52="1.14 - 2.00"
